Esophageal granular cell tumor is a rare submucosal neoplasm of Schwann cell origin, with approximately 1-2% of all granular cell tumors occurring in the esophagus. It typically presents in the distal esophagus, in patients aged 40-60 years, with a slight male predominance. Histopathologically characterized by PAS-positive granular inclusions in the cytoplasm, which are lysosomal in origin and S-100 protein positive. Most lesions are small (<2 cm), benign, and asymptomatic, discovered incidentally during endoscopy. Malignant transformation is rare but should be suspected in lesions >4 cm, with rapid growth or necrosis. Treatment with endoscopic submucosal resection is adequate for small lesions; surgical excision is recommended for large or suspected malignant lesions.
Age Range
30-60
Peak Age
45
Gender
Equal
Prevalence
Rare
Granular cell tumor is a neoplasm of Schwann cell origin, and S-100 protein expression confirms this neural derivation. The granules accumulating in tumor cell cytoplasm are lysosomal autophagic vacuoles containing degraded organelles from cell turnover — this granular appearance is the hallmark histological feature. The lesion grows within the submucosal layer, leaving the overlying mucosa intact, which is why it presents as a well-defined intramural/submucosal mass on CT and barium studies. The notable contrast enhancement reflects the intratumoral capillary network. On T2-weighted MRI, it shows variable but generally mildly hyperintense signal; the solid nature with intracellular granules may cause diffusion restriction. Malignant variants are exceedingly rare (1-2%), characterized by tissue invasion, necrosis, and increased mitotic activity.
A small, homogeneous hypoechoic, well-defined nodule arising from the submucosal layer in the distal esophagus on EUS; endoscopically appearing yellowish-white, firm, and sessile. This combined endoscopic and ultrasonographic finding is highly characteristic of granular cell tumor.
Oval or round, well-defined, homogeneously and moderately enhancing mass in the submucosal layer of the distal esophageal wall. Usually <2 cm in size. Post-contrast density increase is similar to or slightly above the surrounding muscle. Luminal narrowing is minimal and extraesophageal extension is exceedingly rare.
Report Sentence
A well-defined, homogeneously and moderately enhancing submucosal mass measuring approximately ... cm is noted in the distal esophageal wall, which may be consistent with a granular cell tumor.
Endoscopic ultrasound (EUS) demonstrates a homogeneous hypoechoic, well-defined, oval nodule in the submucosal layer (3rd layer) or at the muscularis mucosae level (2nd layer). Internal structure is homogeneous with no cystic component. The muscularis propria layer (4th layer) is intact, supporting benign nature. In malignant variants, margins may be irregular with invasion into surrounding layers.
Report Sentence
EUS demonstrates a homogeneous hypoechoic, well-defined nodule measuring ... mm in the submucosal layer of the distal esophagus; muscularis propria is intact, consistent with granular cell tumor.
On T2-weighted images, the tumor shows isointense or mildly hyperintense signal compared to surrounding muscle tissue. Homogeneous signal pattern is characteristic. Markedly high T2 signal is typically not seen — this feature distinguishes it from leiomyoma or schwannoma. In large lesions, focal T2 signal increase may reflect cystic degeneration or microlithic changes.
Report Sentence
A well-defined, homogeneous submucosal lesion showing isointense/mildly hyperintense signal on T2-weighted sequence is noted in the submucosal layer of the distal esophagus.
On T1-weighted images, the tumor shows isointense signal compared to surrounding muscle tissue. Homogeneous internal structure and smooth margin pattern are preserved. Post-contrast T1-weighted images demonstrate homogeneous, moderate enhancement — this finding supports the diagnosis of a solid submucosal tumor. Intralesional hemorrhage or calcification is typically absent.
Report Sentence
The lesion shows isointense signal to surrounding muscle on T1-weighted sequence with homogeneous moderate post-contrast enhancement.
On non-contrast CT, a small, well-defined, submucosal mass isodense to muscle tissue in the distal esophageal wall. Calcification or fat density components are typically absent. The lesion shows broad-based contact with the esophageal lumen, and intraluminal polypoid extension is a rare finding. Periesophageal fat planes are preserved.
Report Sentence
Non-contrast CT shows a well-defined submucosal mass isodense to muscle tissue in the distal esophageal wall; no calcification or fat density is present.
On diffusion-weighted imaging (DWI), the tumor may show mild to moderate diffusion restriction with ADC values in the lower range for solid tumors. This finding reflects the dense cellular packing of the tumor and restricted free water movement due to intracellular granule accumulation. Marked diffusion restriction may suggest malignancy but can also be inherent to granular cell tumor.
Report Sentence
The lesion shows mild diffusion restriction on DWI with ADC values consistent with solid tumors.
In the portal venous phase, the tumor maintains or slightly increases its arterial phase enhancement — showing a progressive enhancement pattern. Washout pattern is not seen, which is a finding supporting benign nature. Surrounding esophageal mucosa shows normal enhancement and periesophageal fat planes are clear.
Report Sentence
The mass maintains its enhancement in the portal venous phase without washout pattern; the progressive enhancement pattern supports benign nature.
Criteria
Most common type (98%). Small (<2 cm), well-defined, low mitotic activity, no necrosis. S-100 and NSE positive. Endoscopic resection is usually sufficient.
Distinct Features
Homogeneous enhancement, smooth margins, intact muscularis propria layer on EUS. No size increase expected on follow-up.
Criteria
Extremely rare (1-2%). Large (>4 cm), rapid growth, necrosis, high mitotic index (>2/10 HPF), nuclear pleomorphism, spindling, Ki-67 >10%. Can cause local invasion and metastasis.
Distinct Features
Heterogeneous enhancement, necrotic areas, irregular margins, muscularis propria invasion. Can metastasize to lymph nodes and distant sites (lung, liver).
Criteria
Seen in multiple locations in 5-16% of all granular cell tumor cases. Simultaneous lesions may occur in locations outside the esophagus such as skin, tongue, larynx, and bronchus.
Distinct Features
Each lesion should be evaluated independently; multifocality is not an indicator of malignancy. Other locations should be investigated with systemic screening.
Distinguishing Feature
Leiomyoma arises from muscularis propria (4th layer) and is usually larger; granular cell tumor arises from submucosa (3rd layer) and is typically <2 cm.
Distinguishing Feature
GIST is usually larger, shows more prominent hypervascular enhancement, and is c-KIT (CD117) positive; granular cell tumor is S-100 positive, c-KIT negative.
Distinguishing Feature
SCC arises from the mucosal surface, has irregular margins, with prominent luminal narrowing and wall thickening; granular cell tumor is submucosal, well-defined, and covered by intact mucosa.
Distinguishing Feature
Schwannoma shows marked T2 hyperintensity and target sign; granular cell tumor is isointense/mildly hyperintense on T2 and does not show target sign. Both are S-100 positive.
Urgency
routineManagement
surgicalBiopsy
NeededFollow-up
12-monthGranular cell tumor is overwhelmingly benign in course. For small (<2 cm) lesions, EUS-guided FNA or endoscopic submucosal resection (ESD/EMR) is applied for diagnosis and treatment. Surgical excision should be considered for lesions >2 cm. If malignancy is suspected (>4 cm, necrosis, rapid growth), wide surgical excision and lymph node evaluation are required. In multifocal disease, screening of other locations is recommended.
Granular cell tumors are generally benign (1-2% malignant). Endoscopic follow-up is sufficient for small (<10 mm) lesions. Endoscopic resection is performed for larger or symptomatic lesions.